metformin has been researched along with Day Blindness in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cigarrán, S | 1 |
| Rodriguez, ML | 1 |
| Pousa, M | 1 |
| Menéndez, H | 1 |
| Mendez, MJ | 1 |
| Stalenhoef, AF | 1 |
| van Lith-Verhoeven, JJ | 1 |
2 other studies available for metformin and Day Blindness
| Article | Year |
|---|---|
Transient vision loss in a patient with severe metformin-associated lactic acidosis.
Topics: Acidosis, Lactic; Acute Disease; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypoglyc | 2012 |
Blurred vision.
Topics: Adult; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Insulin; Male; Metformin; Retinal Diseases; | 2007 |